About Us

Qubigen is an end-to-end AI drug design company​​​​

​

Qubigen combines a secure partner platform with proprietary, application-specific AI workflows to design, optimize, and deliver actionable drug candidates for our clients and partners. Qubigen is not a self-service compute or modeling environment. All molecular generation, optimization, and analysis is performed by Qubigen’s end-to-end AI workflows as a fully managed drug design service.

​

​​

​

Qubigen’s Key Differentiators in Market ​

 

Patented, Secure Federated AI

Qubigen's technology is 14x faster and 187x more cost-effective, extracting insights from data without moving or directly accessing it.

 

​

Accelerated Drug Development

Our AI-generated drug candidates are optimized for both binding and tailored drug-like properties, accelerating the hit-to-lead stage. Revive your stalled projects with collaborative opportunities, and help cure tough diseases.

 

​

End-to-End Proprietary AI Drug Design System

Qubigen provides unified application-specific AI workflows with a growing virtual network of federated datasets, internally controlled algorithms, and multidisciplinary team (data science, AI, chemistry), plus secure data portal for iterative AI drug generation.

 

​

Proven Success

We are supported by case studies, major institutional partnerships and access to med-chemistry wet labs for molecule design and preclinical testing.